Related Experiment Video
Updated: Aug 11, 2026
09:35
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Published on: March 2, 2017
Recent developments in human oocyte, embryo and blastocyst vitrification: where are we now?
Juergen Liebermann1, Johannes Dietl, Pierre Vanderzwalmen
1University of Wuerzburg, Department of Obstetrics and Gynecology, Josef-Schneider-Strasse 4, Wuerzburg 97080, Germany. juergenliebermann@hotmail.com
Reproductive Biomedicine Online
|January 30, 2004
Summary
Vitrification, a rapid cooling method, avoids ice crystal formation during cryopreservation. This technique shows increasing success and may surpass slow cooling for preserving living cells.
Area of Science:
- Cryobiology
- Cellular Biology
- Reproductive Medicine
Background:
- Cryopreservation aims to maximize cell survival post-thaw.
- Cooling rate and cellular response to cooling are key to successful cryopreservation.
- Slow-rate freezing can cause ice crystal damage during cooling and warming.
Purpose of the Study:
- To review the benefits and challenges of vitrification for embryo cryopreservation.
- To compare vitrification with slow cooling methods in cryobiology.
- To discuss vitrification as a preferred method in clinical embryology.
Main Methods:
- Vitrification utilizes high cooling rates and high cryoprotectant concentrations.
- This method aims to prevent ice crystal formation during cooling and warming.
- The review discusses potential problems and benefits of vitrification.
Main Results:
- Vitrification avoids ice crystal formation, unlike slow-rate freezing.
- There are practical limits to cooling speed and biological limits to cryoprotectant concentration.
- Vitrification methods are demonstrating increasing success rates.
Conclusions:
- Vitrification may be a superior method to slow cooling in cryobiology.
- Post-warming survival is influenced by species, developmental stage, and embryo quality.
- Vitrification presents a promising approach for embryo cryopreservation in clinical settings.
Related Concept Videos
01:57Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
01:33Cleavage and Blastulation
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
01:24In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...